Growth Metrics

Arcus Biosciences (RCUS) Cash from Operations (2017 - 2026)

Arcus Biosciences' quarterly Cash from Operations came in at 138000000.0 in Q1 2026, down 4.55% year-on-year from 144571428.57 in Q1 2025, and down 15.0% quarter-over-quarter from 120000000.0 in Q4 2025.

Arcus Biosciences has reported Cash from Operations for 10 years, with the latest figure at 138000000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Operations fell 4.55% year-over-year to 138000000.0; the trailing twelve-month figure through Mar 2026 stood at 488000000.0 (down 62.67% YoY), and the FY2025 full-year result was 482000000.0, down 183.53% from the prior year.
  • Cash from Operations for Q1 2026 stood at 138000000.0, down from 120000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 654000000.0 in Q1 2022, with the low at 138000000.0 in Q1 2026.
  • Average Cash from Operations over 5 years is 38705882.35, with a median of 88000000.0 recorded in 2023.
  • Year-over-year, Cash from Operations surged 1086.19% in 2022 and tumbled 6500.0% in 2025.
  • Tracing RCUS's Cash from Operations over 5 years: stood at 70000000.0 in 2022, then slipped by 25.71% to 88000000.0 in 2023, then dropped by 13.64% to 100000000.0 in 2024, then declined by 20.0% to 120000000.0 in 2025, then decreased by 15.0% to 138000000.0 in 2026.
  • The last three Cash from Operations figures came in at 138000000.0 (Q1 2026), 120000000.0 (Q4 2025), and 97000000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -1.67 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.43 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 1.08 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 70.50 Mn
10 Arcus Biosciences 3.18 Bn 2.36 Bn - -138.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -138.00 Mn
Mar 31, 2026 -138.00 Mn
Dec 31, 2025 -120.00 Mn
Dec 31, 2025 -120.00 Mn
Sep 30, 2025 -97.00 Mn
Sep 30, 2025 -97.00 Mn
Jun 30, 2025 -133.00 Mn
Jun 30, 2025 -133.00 Mn
Mar 31, 2025 -132.00 Mn
Mar 31, 2025 -132.00 Mn
Dec 31, 2024 -100.00 Mn
Dec 31, 2024 -100.00 Mn
Sep 30, 2024 26.00 Mn
Sep 30, 2024 26.00 Mn
Jun 30, 2024 -94.00 Mn
Jun 30, 2024 -94.00 Mn
Mar 31, 2024 -2.00 Mn
Mar 31, 2024 -2.00 Mn
Dec 31, 2023 -88.00 Mn
Dec 31, 2023 -88.00 Mn
Sep 30, 2023 -63.00 Mn
Sep 30, 2023 -63.00 Mn
Jun 30, 2023 -57.00 Mn
Jun 30, 2023 -57.00 Mn
Mar 31, 2023 -98.00 Mn
Mar 31, 2023 -98.00 Mn
Dec 31, 2022 -70.00 Mn
Dec 31, 2022 -70.00 Mn
Sep 30, 2022 -81.00 Mn
Sep 30, 2022 -81.00 Mn
Jun 30, 2022 -65.00 Mn
Jun 30, 2022 -65.00 Mn
Mar 31, 2022 654.00 Mn
Mar 31, 2022 654.00 Mn
Dec 31, 2021 -61.93 Mn
Dec 31, 2021 -61.93 Mn
Sep 30, 2021 -53.76 Mn
Sep 30, 2021 -53.76 Mn
Jun 30, 2021 -74.00 Mn
Jun 30, 2021 -74.00 Mn
Mar 31, 2021 -66.32 Mn
Mar 31, 2021 -66.32 Mn
Dec 31, 2020 -50.05 Mn
Dec 31, 2020 -50.05 Mn
Sep 30, 2020 216.27 Mn
Sep 30, 2020 216.27 Mn
Jun 30, 2020 -23.94 Mn
Jun 30, 2020 -23.94 Mn
Mar 31, 2020 -31.28 Mn
Mar 31, 2020 -31.28 Mn
Dec 31, 2019 -9.47 Mn
Dec 31, 2019 -9.47 Mn
Sep 30, 2019 -27.40 Mn
Sep 30, 2019 -27.40 Mn
Jun 30, 2019 -19.75 Mn
Jun 30, 2019 -19.75 Mn
Mar 31, 2019 -16.84 Mn
Mar 31, 2019 -16.84 Mn
Dec 31, 2018 -7.11 Mn
Dec 31, 2018 -7.11 Mn
Sep 30, 2018 -11.77 Mn
Sep 30, 2018 -11.77 Mn
Jun 30, 2018 -10.88 Mn
Jun 30, 2018 -10.88 Mn
Mar 31, 2018 -13.25 Mn
Mar 31, 2018 -13.25 Mn
Dec 31, 2017 15.59 Mn
Dec 31, 2017 15.59 Mn
Sep 30, 2017 -24.23 Mn
Sep 30, 2017 -24.23 Mn
Jun 30, 2017 -6.82 Mn
Jun 30, 2017 -6.82 Mn
Mar 31, 2017 -9.60 Mn
Mar 31, 2017 -9.60 Mn